nedosiran
Generic: NEDOSIRAN SODIUM·Brand: RIVFLOZA, Rivfloza
nedosiran: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Dicerna Pharmaceuticals Inc (DRNA) | Phase 2 |
Clinical Trials (1)
Treatment of Primary Hyperoxaluria Type 1 With Nedosiran
Frequently asked questions
Who is developing nedosiran?
nedosiran is being developed by Dicerna Pharmaceuticals Inc.
How many clinical trials involve nedosiran?
BioSniper tracks 1 clinical trial involving nedosiran.
Get deeper analysis on nedosiran
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis